Ora, Inc.: H-1B salaries and sponsorship
Ora, Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $91,188.
Does Ora, Inc. sponsor H-1B visas?
Ora, Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 9, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Associate Biostatistician | 1 | $85,218 |
| Clinical Trial Associate II | 1 | $75,000 |
| Biostatistician | 1 | $97,157 |
| Principal Biostatistician | 1 | $182,490 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 1 | $85,218 |
| FY2025 | 1 | $75,000 |
| FY2026 | 2 | $139,824 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Principal Biostatistician | $182,490 Level III | Jamesburg, NJ | Jun 9, 2026 | Jun 22, 2026 | Certified |
| Biostatistician | $97,157 Level I | Fairfax, VA | May 26, 2026 | Jul 1, 2026 | Certified |
| Clinical Trial Associate II | $75,000–$80,000 Level II | Raleigh, NC | Aug 6, 2025 | Sep 18, 2025 | Certified |
| Associate Biostatistician | $85,218 Level I | Rockville, MD | Jun 3, 2024 | Oct 1, 2024 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).